Skip to main content

Table 1 Demographic and clinicopathologic characteristics for subjects in each stage of the multi-stage design

From: ANKS1B is a smoking-related molecular alteration in clear cell renal cell carcinoma

Ā 

Affymetrix microarray

RT-PCR

Stage 1: non-obese subjects

Stage 2: obese subjects

Stage 3: non-obese subjects

Non-smokers 30 (65%)

Smokers 16 (35%)

p-value

Non-smokers 12 (63%)

Smokers 7 (37%)

p-value

Non-smokers 54 (66%)

Smokers 28 (34%)

p-value

Gender

Ā Ā 

0.2170

Ā Ā 

0.1698

Ā Ā 

0.0273

ā€ƒMale

14 (47%)

11 (69%)

Ā 

4 (33%)

5 (71%)

Ā 

30 (56%)

23 (82%)

Ā 

ā€ƒFemale

16 (53%)

5 (31%)

Ā 

8 (67%)

2 (29%)

Ā 

24 (44%)

5 (18%)

Ā 

Age at surgery

Ā Ā 

0.2537

Ā Ā 

0.8584

Ā Ā 

0.4597

ā€ƒ<50

3 (10%)

3 (19%)

Ā 

2 (17%)

1 (14%)

Ā 

9 (17%)

5 (18%)

Ā 

ā€ƒ50-79

24 (80%)

13 (81%)

Ā 

9 (75%)

6 (86%)

Ā 

41 (76%)

23 (82%)

Ā 

ā€ƒā‰„80

2 (7%)

0

Ā 

1 (8%)

0

Ā 

4 (7%)

0

Ā 

ā€ƒUnknown

1 (3%)

0

Ā 

0

0

Ā 

0

0

Ā 

Nuclear grade

Ā Ā 

0.2032

Ā Ā 

0.5834

Ā Ā 

0.2000

ā€ƒ1

3 (10%)

1 (6%)

Ā 

4 (33%)

2 (29%)

Ā 

5 (9%)

3 (11%)

Ā 

ā€ƒ2

18 (60%)

7 (44%)

Ā 

8 (67%)

4 (57%)

Ā 

17 (32%)

7 (25%)

Ā 

ā€ƒ3

9 (30%)

8 (50%)

Ā 

0

1 (14%)

Ā 

24 (44%)

11 (39%)

Ā 

ā€ƒ4

0

0

Ā 

0

0

Ā 

8 (15%)

7 (25%)

Ā 

Pathologic tumor stage

Ā Ā 

0.0123

Ā Ā 

0.5926

Ā Ā 

0.4713

ā€ƒpT1

24 (80%)

7 (44%)

Ā 

9 (75%)

6 (86%)

Ā 

31 (57%)

11 (39%)

Ā 

ā€ƒpT2

2 (7%)

2 (12%)

Ā 

2 (17%)

1 (14%)

Ā 

4 (7%)

4 (14%)

Ā 

ā€ƒpT3

4 (13%)

7 (44%)

Ā 

1 (8%)

0

Ā 

18 (33%)

13 (46%)

Ā 

ā€ƒpT4

0

0

Ā 

0

0

Ā 

1 (2%)

0

Ā 

Presence of necrosis

Ā Ā 

0.2829

Ā Ā 

1.0000

Ā Ā 

0.4739

ā€ƒYes

5 (17%)

5 (31%)

Ā 

1 (8%)

1 (14%)

Ā 

19 (35%)

13 (46%)

Ā 

ā€ƒNo

25 (83%)

11 (69%)

Ā 

11 (92%)

6 (86%)

Ā 

34 (63%)

15 (54%)

Ā 

ā€ƒUnknown

0

0

Ā 

0

0

Ā 

1 (2%)

0

Ā